- Home
- FDBC vs IKT Comparison
FDBC vs IKT Comparison
Compare FDBC & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDBC | IKT |
|---|---|---|
| Founded | 1902 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.3M | 240.1M |
| IPO Year | 2000 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FDBC | IKT |
|---|---|---|
| Price | $42.70 | $1.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.50 |
| AVG Volume (30 Days) | 4.0K | ★ 2.2M |
| Earning Date | 04-22-2026 | 11-14-2025 |
| Dividend Yield | ★ 3.91% | N/A |
| EPS Growth | 35.00 | ★ 67.51 |
| EPS | ★ 4.86 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.00 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $37.00 | $1.33 |
| 52 Week High | $50.00 | $2.46 |
Technical Indicators
Market Signals| Indicator | FDBC | IKT |
|---|---|---|
| Relative Strength Index (RSI) | 40.30 | 44.35 |
| Support Level | $42.30 | $1.77 |
| Resistance Level | $42.90 | $2.10 |
| Average True Range (ATR) | 1.29 | 0.13 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 31.18 | 6.35 |
Price Performance
Historical ComparisonAbout FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.